Top News

La Jolla Pharmaceuticals Appoints CEO




San Diego-based La Jolla Pharmaceutical Company announced yesterday that it has appointed a new CEO. Deirdre Y. Gillespie, M.D. has joined the firm, replacing Steven B. Engle, who the company said resigned Tuesday. The firm also said that Craig R. Smith, M.D., a director of the company, has been appointed Chairman. Gillespie joins from Oxxon, and has served at Vical and other firms. La Jolla Pharmaceutical is developing therapeutics for the treatment of lupus.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel